Skip to main content
Premium Trial:

Request an Annual Quote

Swiss Biopharma Licenses Dotmatics Suite for Preclinical Research Data Management

Premium

Dotmatics has licensed its informatics suite to Basilea Pharmaceutica, a Swiss biopharmaceutical company, which will use the tools to manage its preclinical research data.

Dotmatics' platform provides tools for registering, analyzing, and managing scientific data; an electronic laboratory notebook for chemistry and biology experiments; and the ability to query, visualize, and report research data.

The suite includes Browser, a web-based tool for querying, browsing and visualizing biological databases; Vortex, a visualization and analytics platform for scientific and non-scientific data; Bioregister, a web-based tool for registering biological entities; Gateway, which enables research teams to share information internally and with external partners; and Register, a chemical registration system; among other tools.

The financial details of the licensing agreement were not disclosed.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.